FindTrial
Sign In

A prospective multicenter randomized controlled clinical study comparing the safety and efficacy of EFRC and ESD in the resection of gastric submucosal tumors

A prospective multicenter randomized controlled clinical study comparing the safety and efficacy of EFRC and ESD in the resection of gastric submucosal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075435
Enrollment
Unknown
Registered
2023-09-05
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric submucosal tumor

Interventions

EFRC:EFRC excision of SMT
ESD:ESD excision of SMT

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years old with gastric SMT; 2. Sign informed consent; 3. The diameter of the tumor is less than 1.5cm; 4. CT or endoscopic ultrasound confirmed that most of the tumor is located in the stomach cavity;

Exclusion criteria

Exclusion criteria: 1. The diameter of the tumor is greater than 1.5cm; 2. Ultrasound confirmed that it was a submucosal hemangioma; 3. Poor coagulation function (PT>15s or APTT>45s or INF>2.0); 4. Patients with severe cardiovascular and cerebrovascular diseases who cannot tolerate surgery (history of stroke and myocardial infarction or severe heart failure new function grade III within 1 month)

Design outcomes

Primary

MeasureTime frame
Complete resection rate of lesion;Surgical safety;—

Secondary

MeasureTime frame
Time of surgery;Surgical complications;—

Countries

China

Contacts

Public ContactWang Yi

The Affiliated Drum Tower Hospital of Nanjing University

wangyired@foxmail.com+86 136 1159 2624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026